Elena Aréchaga-Ocampo

Author

Instituto Nacional de Cancerología ORCID

Also Known As

E Arechaga-Ocampo, ELENA ARECHAGA-OCAMPO, Elena Arechaga-Ocampo, Elena Arechaga‐Ocampo, Elena Arechaga‑Ocampo, Elena Aréchaga-Ocampo, Elena Aréchaga-Ocampo

Publications

944

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Cancerología Universidad Nacional Autónoma de México Universidad Autónoma Metropolitana Instituto Politécnico Nacional Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

About

Elena Aréchaga-Ocampo is an author at Instituto Nacional de Cancerología specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	211
2	Natural Sciences	2	2	38
3	Biology	2	2	38
4	Public Health	1	1	22
5	Biochemistry	1	1	10

Elena Aréchaga-Ocampo

Publications

704

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase II Trial of All-<i>Trans</i>-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer Óscar Arrieta, Claudia Haydée González-De la Rosa, Elena Aréchaga-Ocampo, Journal of Clinical Oncology	2010	124
Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy José Díaz‐Chávez, Miguel A. Fonseca-Sánchez, Elena Aréchaga-Ocampo, PLoS ONE	2013	71
New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR Isidro X. Perez‐Añorve, Claudia Haydée González-De la Rosa, Ernesto Soto‐Reyes, Molecular Oncology	2019	66
microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration Miguel A. Fonseca-Sánchez, Carlos Pérez‐Plasencia, Jorge Fernández‐Retana, Oncology Reports	2013	53
Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells Alejandro García-Regalado, Miguel Vargas, Alejandro Garcı́a-Carrancá, Molecular Cancer	2013	50
Tumor suppressor miR-29c regulates radioresistance in lung cancer cells Elena Aréchaga-Ocampo, César López‐Camarillo, Nicolás Villegas‐Sepúlveda, Tumor Biology Tumor BiologyRadiation MedicineOncologyMedicineMicrornas Contributes	2017	49
Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines Carlos César Patiño-Morales, Ernesto Soto‐Reyes, Elena Aréchaga-Ocampo, Redox Biology Chemoprevention StrategyQuinone Oxidoreductase 1Cancer BiologyTumor BiologyP53 Activity	2019	46
Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non‐small cells lung cancer to chemotherapy Ali Flores‐Pérez, Laurence A. Marchat, Lidia López Sánchez, PROTEOMICS - CLINICAL APPLICATIONS	2015	41
Cloning and expression analysis of hemoglobin genes from maize (Zea mays ssp. mays) and teosinte (Zea mays ssp. parviglumis) Elena Aréchaga-Ocampo, Juán Sáenz-Rivera, Gautam Sarath, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression BiologyPlant GeneticsExpression AnalysisNatural SciencesGenetics	2001	28
RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy Ali Flores‐Pérez, Lourdes E Rafaelli, Nayeli Ramírez‐Torres, Cancer Biology & Therapy Dna Repair ActivityBreast OncologyOncologyMedicinePathology	2014	28

Page 1